Wednesday, February 10, 2021

The grant will fund clinical trials to study the efficacy of psilocybin in treating the emotional suffering associated with terminal medical illness

Investigator(s):
Investigator(s): Charles Grob, MD
Research Theme(s): Neurotherapeutics

LOS ANGELES — The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The grant will also support education and outreach programs related to the use of psilocybin within the field of palliative care.

Tuesday, January 19, 2021

Ashraf S. Ibrahim, PhD, Lead Author, on publication in the world’s No. 1 Scientific Journal for Microbiology

Investigator(s):
Investigator(s): Ashraf Ibrahim, PhD
Research Theme(s): Infection and Immunity

LOS ANGELES — Today Nature Microbiology publishes The Lundquist Institute Investigator Dr. Ashraf Ibrahim and his co-authors’ paper, “Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis.”

Thursday, November 19, 2020

California Institute for Regenerative Medicine (CIRM) Funds New Research on Nanotechnology for Stem Cell Implantation and Diabetes Treatment

Investigator(s):

LOS ANGELES — Two junior Investigators at the The Lundquist Institute, Dr. Eiji Yoshihara and Dr. Lina R. Nih, have received a Quest Award from the California Institute for Regenerative Medicine (CIRM). The Quest Award is for discovery research and aims to promote promising new technologies that could be translated for broad use and improved patient care.

Thursday, November 19, 2020

California Institute for Regenerative Medicine (CIRM) Funds New Research on Nanotechnology for Stem Cell Implantation and Diabetes Treatment

Investigator(s):
Research Theme(s): Translational Genomics

LOS ANGELES — Two junior Investigators at the The Lundquist Institute, Dr. Eiji Yoshihara and Dr. Lina R. Nih, have received a Quest Award from the California Institute for Regenerative Medicine (CIRM). The Quest Award is for discovery research and aims to promote promising new technologies that could be translated for broad use and improved patient care.

Tuesday, October 13, 2020

Dr. Richard Casaburi is a world-renowned expert on COPD

Investigator(s):
Investigator(s): Richard Casaburi, PhD, MD

LOS ANGELES – The Lundquist Institute investigator, Richard Casaburi, PhD, MD, has been presented with the European Respiratory Society’s (ERS) most prestigious honor, the Presidential Award, in recognition of his outstanding work to strengthen respiratory science and medicine worldwide. The award was presented during the ERS annual International Congress 2020 that welcomed more than 33,000 virtual attendees from around the world.

Friday, September 18, 2020

Second Live Virtual Webinar — COVID-19: Pregnancy, Infants & Children on Sept. 30 at 6pm PDT

Investigator(s):

LOS ANGELES — The Lundquist Institute has announced the second in its new series of online webinars, “The Lundquist Community Science Series.” This community service webinar series features internationally-renowned Lundquist investigators and clinician scientists, who will be addressing timely topics in areas of biomedical research and healthcare on a regular basis.

Friday, September 18, 2020

Second Live Virtual Webinar — COVID-19: Pregnancy, Infants & Children on Sept. 30 at 6pm PDT

Investigator(s):

LOS ANGELES — The Lundquist Institute has announced the second in its new series of online webinars, “The Lundquist Community Science Series.” This community service webinar series features internationally-renowned Lundquist investigators and clinician scientists, who will be addressing timely topics in areas of biomedical research and healthcare on a regular basis.

Friday, September 4, 2020

First participants received the shot at The Lundquist Institute on Friday, September 4; more injections scheduled next week

Investigator(s):
Investigator(s): Eric Daar, MD
Research Theme(s): Infection and Immunity

LOS ANGELES – The Lundquist Institute at Harbor-UCLA Medical Center officially began phase 3 trials of the Oxford University – AstraZeneca COVID-19 vaccine trial on Friday, September 4.

Saturday, August 29, 2020

Matthew Budoff, MD presented the EVAPORATE results at the ESC Congress 2020 on August 29, 2020, with concurrent publication in the European Heart Journal

Investigator(s):
Investigator(s): Matthew Budoff, MD

LOS ANGELES — Today, The Lundquist Institute announced that Matthew Budoff, MD, Director of Cardiovascular CT at the Institute and Professor of Medicine at the David Geffen School of Medicine at UCLA, will present the final results of the EVAPORATE study at ESC Congress 2020 (organized by the European Society of Cardiology) with concurrent publication in the European Heart Journal.

Monday, August 3, 2020

Study will allow The Lundquist Institute to determine the multi-generational risks of developing asthma from vaping while pregnant

Investigator(s):
Investigator(s): Virender Rehan, MD

LOS ANGELES - Studies have shown that pregnant women who smoke increase the risk of their children having asthma, and that those children—even if non-smokers—can pass it on to their own children, but few objective studies have evaluated the effects of vaporized nicotine and vapor flavorings. Investigators from The Lundquist Institute, under the leadership of Virender Rehan, MD, have received a $2.3 million grant from the National Institutes of Health (NIH) to research this multi-generational effect of vaping, or smoking an electronic cigarette, while pregnant.